[go: up one dir, main page]

DE3172347D1 - Method for producing an analytical antibody probe, an analytical antibody probe, and a method for analysing a sample for certain antibodies - Google Patents

Method for producing an analytical antibody probe, an analytical antibody probe, and a method for analysing a sample for certain antibodies

Info

Publication number
DE3172347D1
DE3172347D1 DE8181304411T DE3172347T DE3172347D1 DE 3172347 D1 DE3172347 D1 DE 3172347D1 DE 8181304411 T DE8181304411 T DE 8181304411T DE 3172347 T DE3172347 T DE 3172347T DE 3172347 D1 DE3172347 D1 DE 3172347D1
Authority
DE
Germany
Prior art keywords
antibody probe
analytical antibody
analysing
sample
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181304411T
Other languages
English (en)
Inventor
Henry Anthony Erlich
Michael Alan Lovett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of DE3172347D1 publication Critical patent/DE3172347D1/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DE8181304411T 1980-09-24 1981-09-24 Method for producing an analytical antibody probe, an analytical antibody probe, and a method for analysing a sample for certain antibodies Expired DE3172347D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19036180A 1980-09-24 1980-09-24
US29796281A 1981-09-02 1981-09-02

Publications (1)

Publication Number Publication Date
DE3172347D1 true DE3172347D1 (en) 1985-10-24

Family

ID=26886027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181304411T Expired DE3172347D1 (en) 1980-09-24 1981-09-24 Method for producing an analytical antibody probe, an analytical antibody probe, and a method for analysing a sample for certain antibodies

Country Status (10)

Country Link
EP (1) EP0050424B1 (de)
JP (1) JPS57501692A (de)
BR (1) BR8108820A (de)
CA (1) CA1167376A (de)
DE (1) DE3172347D1 (de)
DK (1) DK232882A (de)
ES (1) ES505713A0 (de)
IL (1) IL63907A0 (de)
NO (1) NO821569L (de)
WO (1) WO1982001011A1 (de)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI76888C (fi) * 1981-04-29 1988-12-12 Ciba Geigy Ag Nya medel och foerpackningar foer immunologiska analyser.
FI69639C (fi) * 1982-07-02 1986-03-10 Orion Yhtymae Oy Preparat foer anvaendning vid klamydia-diagnostik
US4863729A (en) * 1984-06-20 1989-09-05 Linus Pauling Institute Of Science And Medicine Method for preparing a macromolecular monoclonal antibody composition
US4647544A (en) * 1984-06-25 1987-03-03 Nicoli David F Immunoassay using optical interference detection
DE3722273A1 (de) * 1986-07-08 1988-01-21 Bio Rad Laboratories Festphasen-bindungsreagentien, ihre herstellung und sie enthaltende assay-kits
NZ221895A (en) * 1986-09-26 1990-09-26 Univ California Composition and method for the diagnosis of pseudomonas aeruginosa infections
US6297027B1 (en) 1996-07-31 2001-10-02 Purina Mills, Inc. Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
US6277592B1 (en) 1996-07-31 2001-08-21 Purina Mills, Inc. Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6103468A (en) * 1997-10-07 2000-08-15 Labatt Brewing Company Limited Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria in beer
JP2003510017A (ja) 1999-06-22 2003-03-18 インビトロジェン コーポレイション 核酸の検出および識別のために改良されたプライマーおよび方法
US6830902B1 (en) 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
DK1431303T3 (en) 1999-09-13 2014-02-17 Nugen Technologies Inc A composition for isothermal linear amplification of polynucleotide sequences
US6692918B2 (en) 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
ES2624689T3 (es) 1999-12-16 2017-07-17 Monsanto Technology Llc Nuevas construcciones de expresión en plantas
MXPA02012735A (es) 2000-06-26 2004-04-20 Nugen Tgechnologies Inc Metodos y composiciones para la amplificacion de acido nucleico a base de transcripcion.
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
EP1366191A2 (de) 2000-12-11 2003-12-03 Alexion Pharmaceuticals, Inc. 'nested' haarnadelförmige oligonukleotide zur amplifizierung von nukleinsäure
US6858413B2 (en) 2000-12-13 2005-02-22 Nugen Technologies, Inc. Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
US6794141B2 (en) 2000-12-22 2004-09-21 Arcturus Bioscience, Inc. Nucleic acid amplification
US6635451B2 (en) 2001-01-25 2003-10-21 Abbott Laboratories Desaturase genes and uses thereof
CA2439074A1 (en) 2001-03-09 2002-09-19 Nugen Technologies, Inc. Methods and compositions for amplification of rna sequences
KR20030082535A (ko) 2001-03-09 2003-10-22 뉴젠 테크놀로지스 인코포레이티드 Ｒｎａ 서열의 증폭을 위한 방법 및 조성물
EP1950305A1 (de) 2001-05-09 2008-07-30 Monsanto Technology, LLC Tyr-A-Gene und ihre Verwendung
AU2002308633A1 (en) 2001-05-09 2002-11-18 Monsanto Technology Llc Metabolite transporters
US7291477B2 (en) 2001-07-03 2007-11-06 Xenotope Diagnostics, Inc. Method and device for trichomonas detection
US7414111B2 (en) 2001-09-19 2008-08-19 Alexion Pharmaceuticals, Inc. Engineered templates and their use in single primer amplification
EP1436404B1 (de) 2001-09-19 2009-11-11 Alexion Pharmaceuticals, Inc. Manipulierte matrizen und ihre verwendung bei der single-primer-amplifikation
US20030165859A1 (en) 2001-10-23 2003-09-04 Invitrogen Corporation Primers and methods for the detection and discrimination of nucleic acids
US7211656B2 (en) 2002-01-30 2007-05-01 Abbott Laboratories Desaturase genes, enzymes encoded thereby, and uses thereof
ATE473281T1 (de) 2002-05-15 2010-07-15 Monsanto Technology Llc Verfahren zur erhöhung des samengewichtes in einer pflanze
WO2003100019A2 (en) 2002-05-24 2003-12-04 Invitrogen Corporation Nested pcr employing degradable primers
EP1540009B1 (de) 2002-08-05 2011-09-28 Quanta Biosciences, Inc. Verbesserte zusammensetzungen zur in-vitro-amplifikation von nukleinsäuren
AU2003275128A1 (en) 2002-09-23 2004-04-08 E. I. Du Pont De Nemours And Company Isolation and use of ryanodine receptors
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
EP1613778B1 (de) 2003-04-14 2014-11-26 Nugen Technologies, Inc. Globale amplifizierung unter verwendung von zufallsgeprimeten zusammen gesetzten primern
US7807874B2 (en) 2003-12-10 2010-10-05 Monsanto Technology Llc Stress tolerant plants and methods thereof
AU2005250074B2 (en) 2004-06-04 2011-04-14 Fluxome Sciences A/S Metabolically engineered cells for the production of polyunsaturated fatty acids
US7456270B2 (en) 2004-09-01 2008-11-25 Abbott Laboratories Δ6-desaturase genes and uses thereof
CA2581086C (en) 2004-09-14 2023-11-07 The Regents Of The University Of Colorado, A Body Corporate Method for treatment with bucindolol based on genetic targeting
US7790363B2 (en) 2005-02-07 2010-09-07 Abbott Laboratories Inc. Diagnostic test for vitamin B12
US8624027B2 (en) 2005-05-12 2014-01-07 Abbvie Inc. Combination therapy for treating cancer and diagnostic assays for use therein
US8017103B2 (en) 2005-07-01 2011-09-13 Board Of Regents, The University Of Texas System Methods and compositions to diagnose trichomonas infection
AU2006279420B2 (en) 2005-08-16 2010-12-16 Merlogen, Llc Methods for identification of merle gene
CA2621267A1 (en) 2005-09-07 2007-03-15 Nugen Technologies, Inc. Improved nucleic acid amplification procedure
US7439028B2 (en) 2005-09-30 2008-10-21 Board Of Regents, The University Of Texas System Methods and compositions to correlate Trichomonas infection with prostate cancer
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
ES2453941T5 (es) 2005-11-30 2017-05-31 Abbvie Inc. Anticuerpos monoclonales contra la proteína beta amiloide y usos de los mismos
US7803567B2 (en) 2005-12-09 2010-09-28 Board Of Regents, The University Of Texas System Methods and compositions for detecting trichomonas in a sample contacted with fixative
US7285388B1 (en) 2006-04-07 2007-10-23 Merlogen, Llc Methods for identification of alport syndrome
US8933209B2 (en) 2006-04-26 2015-01-13 Abbvie Inc. Dep2 and its uses in major depressive disorder and other related disorders
EP2455489A3 (de) 2006-05-25 2012-07-11 Monsanto Technology LLC Verfahren zur Identifizierung von krankheitsresistenten quantitative trait loci in Sojabohnen und Zusammensetzungen damit
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
CA2697860C (en) 2007-08-29 2019-01-15 Monsanto Technology Llc Method and compositions for breeding for preferred traits associated with goss` wilt resistance in plants
US8034568B2 (en) 2008-02-12 2011-10-11 Nugen Technologies, Inc. Isothermal nucleic acid amplification methods and compositions
US8268981B2 (en) 2008-03-06 2012-09-18 Abbott Laboratories Plasmodium malariae and plasmodium ovale genes and uses thereof
US8030471B2 (en) 2008-03-06 2011-10-04 Abbott Laboratories Plasmodium malariae and Plasmodium ovale genes and uses thereof
WO2009117698A2 (en) 2008-03-21 2009-09-24 Nugen Technologies, Inc. Methods of rna amplification in the presence of dna
BRPI0911551B8 (pt) 2008-04-24 2023-10-03 Monsanto Technology Llc Método para produzir planta de soja resistente a ferrugem asiática da soja (asr)
CN102239254B (zh) 2008-10-06 2014-02-26 雅培制药有限公司 △-8去饱和酶基因、由其编码的酶及其用途
US8288124B2 (en) 2008-11-20 2012-10-16 Abbott Laboratories Cloning, expression and purification of recombinant porcine intrinsic factor for use in diagnostic assay
JP5651125B2 (ja) 2008-12-10 2015-01-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｍｅｋ阻害剤に対する耐性を付与するｍｅｋ突然変異
EP2479288A1 (de) 2009-01-31 2012-07-25 Abbott Laboratories Marker zur Vorhersage und Überwachung der Reaktion auf eine Therapie mit einem Aurorakinase-B-Inhibitor
CN102388151A (zh) 2009-02-11 2012-03-21 雅培制药有限公司 用于鉴定、分类和监控具有bcl-2家族抑制剂抗性肿瘤和癌症的受试者的方法和组合物
US8063193B2 (en) 2009-03-27 2011-11-22 Abbott Laboratories Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
CA2761946A1 (en) 2009-05-14 2010-11-18 The Regents Of The University Of California, A California Corporation Carcinoma diagnosis and treatment, based on odc1 genotype
JP2012531926A (ja) 2009-06-30 2012-12-13 アボット ラボラトリーズ Ｘｍｒｖ感染のマーカーとその使用
US8188335B2 (en) 2009-07-17 2012-05-29 Abbott Laboratories Δ9-elongase for production of polyunsaturated fatty acid-enriched oils
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
CA2822747A1 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
EP2538943B1 (de) 2010-02-25 2016-03-30 Dana-Farber Cancer Institute, Inc. Braf-mutationen für resistenz gegen braf-inhibitoren
CA2791247C (en) 2010-03-09 2019-05-14 Dana-Farber Cancer Institute, Inc. Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
EP2558494B1 (de) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta-bindende proteine
EP2568978B1 (de) 2010-05-14 2019-04-24 Arizona Board of Regents on Behalf of University of Arizona Krebsvorbeugung und -behandlung basierend auf polyamin-nahrungsmittelgehalt
PL2580322T3 (pl) 2010-06-09 2018-09-28 Dana-Farber Cancer Institute, Inc. Mutacja mek1 wykazująca odporność na inhibitory raf i mek
EP3533803B1 (de) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antikörper
WO2012024518A1 (en) 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
US20120058461A1 (en) 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
WO2012149193A2 (en) 2011-04-29 2012-11-01 Monsanto Technology Llc Diagnostic molecular markers for seed lot purity traits in soybeans
HUE059863T2 (hu) 2011-08-31 2023-01-28 Seminis Vegetable Seeds Inc Eljárás és készítmények görögdinnye keménységhez
US10314253B2 (en) 2012-12-04 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and compositions for watermelon sex expression
US10294489B2 (en) 2013-03-15 2019-05-21 Board Of Trustees Of Southern Illinois University Soybean resistant to cyst nematodes
US10059999B2 (en) 2013-06-10 2018-08-28 Monsanto Technology Llc Molecular markers associated with soybean tolerance to low iron growth conditions
NZ784204A (en) 2013-11-27 2022-10-28 Seminis Vegetable Seeds Inc Disease resistance loci in onion
MX369780B (es) 2014-02-21 2019-11-21 Syngenta Participations Ag Loci geneticos asociados con una mayor fertilidad en el maiz.
NZ630710A (en) 2014-02-27 2016-03-31 Seminis Vegetable Seeds Inc Compositions and methods for peronospora resistance in spinach
US10316369B2 (en) 2014-06-27 2019-06-11 Seminis Vegetable Seeds, Inc. Methods and assays for male sterile watermelon
EP3005862A1 (de) 2014-10-10 2016-04-13 Seminis Vegetable Seeds, Inc. Melonenpflanzen mit verbesserter krankheitstoleranz
US10448595B2 (en) 2015-09-03 2019-10-22 Seminis Vegetable Seeds, Inc. Downy mildew resistant lettuce plants
EP3199642A1 (de) 2016-02-01 2017-08-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Pflanzenzucht mithilfe von sequenzierung mit grossem durchsatz
CA3018875A1 (en) 2016-03-24 2017-09-28 Tragara Pharmaceuticals, Inc. Treatment of cancer with tg02
SG11201808729WA (en) 2016-04-12 2018-11-29 Univ Michigan Regents Bet protein degraders
WO2018052949A1 (en) 2016-09-13 2018-03-22 The Regents Of The University Of Michigan Fused 1,4-diazepines as bet protein degraders
EP3512855B1 (de) 2016-09-13 2022-07-27 The Regents of the University of Michigan Kondensierte 1,4-oxazepine als bet-protein-abbauer
AU2017232187B2 (en) 2016-09-30 2023-11-09 Seminis Vegetable Seeds, Inc. Xanthomonas resistant brassica oleracea plants
KR20200052294A (ko) 2017-08-14 2020-05-14 에피자임, 인코포레이티드 Setd2의 저해에 의한 암의 치료 방법
WO2019035985A1 (en) 2017-08-18 2019-02-21 Tragara Pharmaceuticals, Inc. POLYMORPHIC FORM OF TG02
WO2019055444A1 (en) 2017-09-13 2019-03-21 The Regents Of The University Of Michigan DEGRADATION AGENTS OF BROMODOMAIN BET PROTEIN WITH CLEAR BINDERS
WO2020037079A1 (en) 2018-08-14 2020-02-20 Epizyme, Inc. Substituted indoles and methods of use thereof
KR20210072043A (ko) 2018-10-08 2021-06-16 더 리젠츠 오브 더 유니버시티 오브 미시간 소분자 mdm 2 단백질 분해제
CA3145881A1 (en) 2019-01-15 2020-07-23 Seminis Vegetable Seeds, Inc. Green bean plants with improved resistance to sclerotinia sclerotiorum and genetic markers therefor
JP2022536419A (ja) 2019-06-12 2022-08-16 ヴァンダービルト ユニバーシティー アミノ酸輸送阻害剤及びその使用
CA3141414A1 (en) 2019-06-12 2020-12-17 Vanderbilt University Dibenzylamines as amino acid transport inhibitors
SG10202008262UA (en) 2019-09-26 2021-04-29 Seminis Vegetable Seeds Inc Lettuce plants having resistance to nasonovia ribisnigri biotype nr:1
AU2021204717A1 (en) 2020-07-15 2022-02-03 Seminis Vegetable Seeds, Inc. Green Bean Plants with Improved Disease Resistance
US20230193310A1 (en) 2021-12-10 2023-06-22 Seminis Vegetabe Seeds, Inc. Lettuce plants having resistance to downy mildew
US20230404003A1 (en) 2022-06-21 2023-12-21 Seminis Vegetable Seeds, Inc. Novel qtls conferring resistance to cucumber mosaic virus
WO2024215744A1 (en) 2023-04-14 2024-10-17 Seminis Vegetable Seeds, Inc. Methods and compositions for peronospora resistance in spinach

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941876A (en) * 1973-04-25 1976-03-02 Gte New Ventures Corporation In vitro method for determining allergic hypersensitivity
FR2233024A1 (en) * 1973-06-15 1975-01-10 Greyward Lab Interconti Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen
US3979509A (en) * 1974-09-03 1976-09-07 General Electric Company Opaque layer method for detecting biological particles
US3952091A (en) * 1974-10-23 1976-04-20 Hoffmann-La Roche Inc. Simultaneous multiple radioimmunoassay
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4094759A (en) * 1975-01-03 1978-06-13 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for simultaneous quantitative analysis of several constituents in a sample
US4097149A (en) * 1975-02-03 1978-06-27 Aladjem Frederick J Quantitative protein analysis by immunodiffusion
FR2353856A1 (fr) * 1976-06-02 1977-12-30 Chateau Guy Ruban destine a servir de support a une reaction par exemple chimique ou biochimique, et procede d'analyse le mettant en oeuvre
US4294817A (en) * 1977-11-25 1981-10-13 International Diagnostic Technology, Inc. Method of fluoro immunoassay
EP0017460A1 (de) * 1979-04-02 1980-10-15 Research Corporation Immunofluoreszenz-Testmethode und Substanz zur Verwendung darin

Also Published As

Publication number Publication date
DK232882A (da) 1982-05-24
ES8303072A1 (es) 1983-02-01
ES505713A0 (es) 1983-02-01
EP0050424A1 (de) 1982-04-28
EP0050424B1 (de) 1985-09-18
BR8108820A (pt) 1982-08-24
NO821569L (no) 1982-05-12
JPS57501692A (de) 1982-09-16
IL63907A0 (en) 1981-12-31
WO1982001011A1 (en) 1982-04-01
CA1167376A (en) 1984-05-15

Similar Documents

Publication Publication Date Title
DE3172347D1 (en) Method for producing an analytical antibody probe, an analytical antibody probe, and a method for analysing a sample for certain antibodies
JPS57115199A (en) Apparatus and method for analyzing sample analyte
GB2029012B (en) Method and apparatus for analyzing whole blood samples
GB2095831B (en) Monoclonal antibody reagent and method for immunological assay
IL51668A0 (en) Analytical method for the quantitative determination on immunogens and antibodies
JPS53108904A (en) Reagent for concurrent protein bond analyzing method
IL51636A (en) Method and apparatus for analysing the concentration of antigen or antibody by radioimmunoassay
JPS5325490A (en) Reagent for analyzing proteins and method of analyzing proteins
GB2045929B (en) Photometric analysis of a succession of samples adding reagents in situ
NO161287C (no) Homogen immunologisk analysemetode, reagensmidler og proeveinnretning for bruk ved immunoanalysebestemmelse.
DE3174968D1 (en) Antibody detection process and reagents therefor
DE3175289D1 (en) Method for operating an apparatus for analysing samples optically
ES551494A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivos con antigenos de esporozoitos o merozoitos de eimeria spp.
EP0058428A3 (en) Method for measuring substances by enzyme immunoassay and test vessel for carrying out this method
AU521481B2 (en) Reagent and method for australia antigen radioimmunoassay
DE3571504D1 (en) Method for immunologically measuring antigens, antibodies or haptens, the use of this method for measuring lipoproteins and alpha-fetoprotein and test kits for the performance of this method
ES531436A0 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
GB2236185B (en) Process,specimen and device for making an analyte available for an investigation
DE3377813D1 (en) Method for quantitative analysis using analytical element sheet
ES546696A0 (es) Procedimiento de preparar anticuerpos monoclonales y metodo de preparar reactivos para detectar canceres
EP0147848A3 (en) Method for the determination of a polyvalent antigen, and reagent therefor
DE3365766D1 (en) Method for non-destructive, qualitative testing of properties of materials
DE3478508D1 (en) Method and apparatus for analyzing a hydrocarbon sample
ES522186A0 (es) Metodo de ensayo de anticuerpos.
JPS54158994A (en) Method and reagent for measuring antigen substance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee